Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

July 05, 2015 11:49 AM ET


Company Overview of AutoGenomics, Inc.

Company Overview

AutoGenomics, Inc., a molecular diagnostics company, provides automated microarray technology solutions for molecular diagnostics. It develops an automated, microarray based multiplexing diagnostic platform for assessing disease signatures with novel genomic and proteomic markers in the area of genetic disorders, infectious disease, cancer, and pharmacogenetics. The company also provides INFINITI System, a multiplexing, continuous flow, random access microarray platform that offers high performance genetic marker detection with varying options in automation and throughput; and INFINITI PLUS Analyzer, an automated, multiplexing, continuous flow, and random access microarray instrument that in...

2980 Scott Street

Vista, CA 92081

United States

Founded in 1999

114 Employees





Key Executives for AutoGenomics, Inc.

Founder, Chairman, Chief Executive Officer, President and Member of Nominating & Corporate Governance Committee
Age: 72
Co-Founder and Senior Vice President of Lab Services
Age: 67
Co-Founder and Vice President of System Development
Age: 76
Chief Financial Officer and Secretary
Age: 66
Chief Medical Officer
Compensation as of Fiscal Year 2015.

AutoGenomics, Inc. Key Developments

AutoGenomics, Inc. and Genomas Announce Strategic Partnership for the Development of DNA-Guided Diagnostic Systems for the Treatment of Cardiovascular Disease, Obesity and Diabetes

AutoGenomics, Inc. and Genomas announced that they have signed an agreement to jointly develop genetic tests and DNA-guided diagnostic systems for optimal selection of statins and for improved delivery of statin therapy for the treatment of cardiovascular disease, obesity and diabetes. This pioneering collaboration will provide clinicians and physicians with newly developed genetic tests and a decision support system which will allow them to manage statins, prescribe and dose these drugs on a DNA-guided, personalized basis to more effectively guide the therapy for each patient.

AutoGenomics, Inc. Presents at 26th Annual ROTH Conference, Mar-11-2014 04:00 PM

AutoGenomics, Inc. Presents at 26th Annual ROTH Conference, Mar-11-2014 04:00 PM. Venue: The Ritz Carlton, 1 Ritz Carlton Dr, Dana Point, CA 92629, United States.

Similar Private Companies By Industry

Company Name Region
Neogenix Oncology, Inc. United States
Genomic Expression Inc. United States
Caribou Biosciences, Inc. United States
Trophogen, Inc. United States
Fisher Scientific Global Laboratory Products United States

Recent Private Companies Transactions

No transactions available in the past 12 months.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact AutoGenomics, Inc., please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at